SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $249,579 | -46.1% | 12,129 | +23.3% | 0.00% | -100.0% |
| Q2 2023 | $462,640 | -17.5% | 9,840 | -26.3% | 0.00% | 0.0% |
| Q1 2023 | $560,543 | +6.2% | 13,360 | -3.3% | 0.00% | 0.0% |
| Q4 2022 | $528,000 | -1.5% | 13,823 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $536,000 | +19.9% | 13,673 | -1.0% | 0.00% | 0.0% |
| Q2 2022 | $447,000 | +18.3% | 13,814 | +21.1% | 0.00% | 0.0% |
| Q1 2022 | $378,000 | +27.7% | 11,406 | +63.6% | 0.00% | 0.0% |
| Q4 2021 | $296,000 | +166.7% | 6,974 | +175.7% | 0.00% | – |
| Q3 2021 | $111,000 | -78.9% | 2,530 | -72.5% | 0.00% | -100.0% |
| Q2 2021 | $527,000 | +621.9% | 9,211 | +852.5% | 0.00% | – |
| Q1 2021 | $73,000 | -26.3% | 967 | -15.2% | 0.00% | – |
| Q4 2020 | $99,000 | +219.4% | 1,141 | +121.1% | 0.00% | – |
| Q3 2020 | $31,000 | -3.1% | 516 | -35.3% | 0.00% | – |
| Q2 2020 | $32,000 | +28.0% | 798 | -10.6% | 0.00% | – |
| Q1 2020 | $25,000 | – | 893 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |